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Abstract
Background: Osteoarthritis (OA) is a degenerative disease, considered to be one of the major public health
problems. Research suggests that patient education is feasible and valuable for achieving improvements in quality
of life, in function, well-being and improved coping. Since 1994, Primary Health Care in Malmö has used a patient
education programme directed towards OA. The aim of this study was to evaluate the effects of this education
programme for patients with OA in primary health care in terms of self-efficacy, function and self-perceived health.
Method: The study was a single-blind, randomized controlled trial (RCT) in which the EuroQol-5D and Arthritis self-
efficacy scale were used to measure self-perceived health and self-efficacy and function was measured with Grip
Ability Test for the upper extremity and five different functional tests for the lower extremity.
Results: We found differences between the intervention group and the control group, comparing the results at
baseline and after 6 months in EuroQol-5D (p < 0.001) and in standing one leg eyes closed (p = 0.02) in favour of
the intervention group. No other differences between the groups were found.
Conclusion: This study has shown that patient education for patients with osteoarthritis is feasible in a primary
health care setting and can improve self-perceived health as well as function in some degree, but not self-efficacy.
Further research to investigate the effect of exercise performance on function, as well as self-efficacy is warranted.
Trial registration: The trial is registered with ClinicalTrials.gov. Registration number: NCT00979914
Background
Osteoarthritis (OA) is a degenerative disease, considered
to be one of the major public health problems [1]. The
predominant symptoms are pain, stiffness and impaired
quality of life along with psychological distress [2].
Treatment often consists of medication. Later in the dis-
ease, joint replacement surgery commonly occurs. Carti-
lage as well as function and quality of life can be
influenced positively by physical exercises [3-5]. Physical
exercise may also reduce the need for hospital care after
knee joint replacement [6].
Patient education programmes are often defined as a
planned learning experience to influence a patient’s
knowledge and health behaviour [7]. Education can be
given by a physician as part of a consultation, in small
groups or delivered by multidisciplinary team [7,8].
Research suggests that patient education is feasible and
valuable in terms of improvements in quality of life, func-
tion, well-being and improved coping [9-13]. In research
on patient education for OA, several different forms of
patient education can be implemented, some of them only
self-management programmes, some only exercise pro-
grammes and some programmes combining self-manage-
ment and exercise. Systematic reviews have been
performed which address the different types of pro-
grammes, with varying conclusions [9,14,15]. Devos-
Comby et al concluded that self-management programmes
had little effect on function but somewhat more on
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psychological health [9]. Walsh et al concluded that
programmes with a combination of exercises and self-
management programmes and exercises combined could
reduce pain and increase function [15]. In contrast, Cho-
dosh et al concluded that self-management programmes
for OA did not have any effect on pain or function [14].
One difference in the systematic reviews is the addition of
exercise to traditional self-management, which might
explain the contradictory results. Despite the uncertainty
in findings, guidelines recommend education as a core
treatment for osteoarthritis [16].
Since 1994, Primary Health Care in Malmö has used a
patient education programme directed towards OA and
delivered by a multi-disciplinary team. The programme
has been developed by physiotherapists and occupa-
tional therapists in primary health and includes informa-
tion on exercise and self-management.
The aim of this study was to evaluate the effects of
this education programme for patients with OA in pri-




The patients were referred to the patient education pro-
gramme for osteoarthritis (PEPOA) by their GP, ortho-
paedic specialist, physiotherapist or occupational
therapist. Inclusion criteria in the study were patients of
any age with OA in the knee, hip or hand with pain,
stiffness and limitation of movement in the affected
joint. Exclusion criteria were inability to speak and
understand Swedish.
Outcome measures
The main outcome measure for self-perceived health
was the generic instrument EuroQol-5D (EQ5D) [17,18].
EQ5D comprises five dimensions: mobility, self-care,
usual activities, pain/discomfort and anxiety/depression.
Each dimension has three levels: no problems, some
problems, severe problems. The patient indicates his/her
state by placing a cross in the box for the most appro-
priate statement. This result in a 1-digit number and
the digits for the five dimensions can be combined in a
five-digit number, generating 243 possible combinations
of responses. The EQ5D can be presented as a health
profile or as a global health index with a weighted total
value (British tariff used), where the minimum value is
-0.594 and the maximum 1.0 [19]. The EQ5D also con-
sists of a Visual Analogue Scale (EQ5D-VAS), where
patients are asked to rate their health on a vertical scale,
where 100 is best imaginable health state, and 0 is worst
imaginable health state. EQ5D is widely used for moni-
toring health status among different patient groups all
over the world [18]. It has been used for measuring
outcome of intervention among patients with OA [20],
with chronic conditions [21] and as a predictor of out-
come after hip replacement surgery [22].
The main outcome measure for self-efficacy was the
generic instrument Arthritis Self-Efficacy Scale (ASES)
[23]. ASES consists of three items: pain, function and
other symptoms. For each item there are a number of
questions about how confident the patient feels about
performing an activity or a task. Answers are given on a
visual analogue scale, where 10 is not confident at all
and 100 very confident. The mean value for each item is
calculated. ASES has been used for evaluating patient
education programmes for patients with arthritis [23]
and for patients with chronic pain, and the Swedish ver-
sion has been tested for reliability and validity [24,25].
As the main outcome measure for function in the
lower extremities, one-leg rising from sitting to standing
was used, with the patient being asked to rise from a
stool, 48 cm high, as many times as possible. If the
patient was not able to rise from 48 cm, one-legged ris-
ing from 60 cm was used. Bipedal rising from sitting to
standing and one-legged jump were used as secondary
outcome measures for function in the lower extremities.
In bipedal rising from sitting to standing, the patient
was asked to rise from a stool, 48 cm high, using both
legs, as many times as possible. Bipedal rising has been
used for assessing patients with fibromyalgia syndrome
[26]. In one-legged jump, [27] the distance from heel in
the starting position to heel in the landing position was
measured. The one-legged jump has been used for
assessing patients after meniscectomy [28]. To measure
balance performance, standing one leg eyes open
(SOLEO) and standing one leg eyes closed (SOLEC)
were used. In SOLEO and SOLEC the patient was
standing with arms crossed [29]. The time, up to 60 sec-
onds was measured. SOLEO and SOLEC have been used
in primary care settings [30,31]. Bipedal rising, single-leg
standing, SOLEO and one-legged jump have been tested
for reliability [26,28,32]. Bipedal rising has shown accep-
table interrater reliability (mean 1.1, SD 2.0, correlation
coefficients 0.96, interrater coefficient variation 7.6) [26],
SOLEO has shown high interrater reliability (Spearman
Rank-Order Correlations -0.38 to -0.45) [32] and one-
legged jump has shown good test-retest reliability
(ICC 0.92, 95%CI 0.86 to 0.96 and 0.93, 95% CI 0.87 to
0.97) [28].
The main outcome measure for function in the upper
extremity was the Grip Ability Test (GAT) [33]. GAT
consists of three items; putting a flexigrip stocking over
the non-dominant hand, putting a paper clip on an
envelope and pouring water from a jug. The time for
each item is measured and calculated in a total score. A
high score corresponds to decrease in hand function.
GAT has been tested for reliability and internal
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consistency (intraobserver test r = 0.985, p < 0.001;
interobserver test r = 0.948, p < 0.001; internal consis-
tency (Cronbach’s alpha) 0.65) [33] and has been used
for patients with rheumatoid arthritis [34].
All measures were performed in the same order for
each patient, both at baseline and at follow-up.
Randomization process
All patients were tested at baseline with the aforemen-
tioned clinical measures and completed ASES and
EQ-5D. Tests at baseline were performed by either a
physiotherapist or an occupational therapist. After com-
pletion of the assessment, the tester informed the
patient about the study. If the patient agreed to partici-
pate, informed consent was obtained. Then an indepen-
dent person randomized the patient to either the
intervention group or the control group, using a random
number list and sealed envelopes.
Intervention
The intervention group participated in PEPOA and the
control group continued living as usual. PEPOA consists
of five group sessions, three hours for each session,
once a week for five weeks. The focus was on self-
efficacy. Eight to ten patients participated in the pro-
gramme at the same time. The programme is described
in detail in table 1.
After six months, all patients were assessed with the
same tests as at baseline, as well as ASES and EQ-5D.
An independent person performed the six-month tests.
After these measures, the patients in the control group
were invited to participate in PEPOA.
In the planning of the present study, a pilot study was
performed where we found the intervention as well as
the measures suitable for a larger study [35].
Statistics
Considering a standard deviation of 12 for one-leg rising
[27], 13.3 for SOLEO, 7.4 for SOLEC [36], 0.18 for
EQ5D [37] and the assumed clinically relevant difference
of 3 for SOLEC [31], 0.09 for EQ5D [37] and one stan-
dard deviation for the other tests, a power of 80% at sig-
nificance level 0.05, it was deemed that a sample size of
100 persons was required [38].
Since data were normally distributed, the one-way
ANOVA was used to calculate differences between the
two groups when data were quantitative. The Wilcoxon
signed ranked test was used for calculating differences
between the two groups in the proportion of levels in
EQ5D. Since a visual analogue scale is a construct scale,
the Wilcoxon signed ranked test was also used to calcu-
late differences between the groups [39]. Data were cal-
culated with an intention-to-treat analysis. The
significance level was set at p ≤ 0.05.
The data package SPSS version 16.0 was used (SPSS
Inc, software location Lund University).
Ethics
The study was approved by the Regional Ethical Review
Board in Lund.
Results
A total of 120 patients were assessed for eligibility in the
study, of whom 114 patients agreed to participate and
were randomized to either intervention group or control
group. Six patients did not want to participate in the
study and were excluded before randomization. A total
of 100 patients were assessed after 6 months.
The 114 patients (97 women) who were included in
the study were between 41 and 84 years old, mean age
63. The most common OA-affected joints were knee
and hand. Sixty-eight per cent of the patients had BMI
25 or more. Baseline data for intervention group and
control group are shown in table 2. As seen in table 2,
there were no statistically significant differences between
the groups at baseline. Fourteen patients did not com-
plete the study, 10 in the intervention group and 4 in
the control group. The patients who dropped out were
Table 1 The patient education programme for osteoarthritis (PEPOA)
Session Content
First session Physiotherapist and occupational therapist at the same time. Information about anatomy, about physiology of pain and coping with
pain. Try cold and heat. Brainstorming about what the participants finds hard to do.
Second
session
Physiotherapist. Information about exercise and physical activity. Practical demonstration of home-training exercises for the lower
extremity. Demonstration of different kinds of orthopaedic aids for the lower extremity.




Occupational therapist. Ergonomics and practical instructions about equipment and technical aids. Feedback to the brainstorming
from session one.
Fifth session Occupational therapist. Information about surgery of the hand, demonstration of orthopaedic aids for hands. Try out treatment with
hot paraffin. Practical demonstration of home training exercises for the hand.
The programme lasted for five weeks, with group sessions once a week, three hours for each session.
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between 47 and 81 years old, mean 63 years. There were
13 women and one man in the dropout group. A flow-
chart of the study is shown in figure 1.
Results in function, self-efficacy and self-perceived
health after 6 months are shown in table 3 and table 4.
There were statistically significant differences between
the two groups in EQ5D levels in the five dimensions,
with the intervention group having a higher proportion
of patients in level 1 (no problems) after 6 months in all
the dimensions (mobility, self-care, usual activities, pain/
discomfort and anxiety/depression) (p < 0.001). There
were also statistically significant differences between the
groups in EQ5D-VAS (p = 0.02), where the intervention
group had improved more than the control group, but
there was no statistically significant difference in ASES
(table 3 and table 4).
There were statistically significant differences between
intervention group and the control group after 6 months
in SOLEC (p = 0.02), where the intervention group had
improved more than the control group (table 3).
Discussion
Main findings
In this randomized controlled trial, we found improve-
ments in SOLEC (p = 0.02), in EQ5D-VAS (p = 0.02)
and in proportions of patients who were at the different
levels in EQ5D (p < 0.001) after a patient education pro-
gramme for osteoarthritis.
Limitations of the study’s methods
As in all randomized controlled trials concerning reha-
bilitation, it is not possible to use a double-blind design,
since the patients always know whether they are in the
intervention group or the control group. The present
study has a single-blind design, with measurements at
baseline and after six months performed by either a
physiotherapist or an occupational therapist, who did
not know whether the patient had been in the interven-
tion group or the control group. This design possibly
minimizes the risk of confounding factors. Also, to
make sure that the assessor was blinded, another asses-
sor performed tests after 6 months. Since the outcome
measures have been tested for reliability, we do not
think that this has compromised the results [26,28,32].
However, being thoroughly assessed is a form of inter-
vention that may make the patient aware of his or her
weaknesses, such as poor ability to rise from a chair.
Therefore, it is possible that the patients in the control
group performed exercises by themselves, or found
information about osteoarthritis on their own.
Measures were performed at baseline and after 6
months. After baseline measures, there was a waiting
time for participation in PEPOA of approximately one
to three months. This means that the six-month mea-
sures were performed between one and a half and three
and a half months post-treatment for the intervention
group. It is possible that this has diluted our findings.
Table 2 Baseline data for the study group, mean values, range and standard deviation (SD).
Intervention Control
n = 61 n = 53
Measures Mean Range SD Mean Range SD p
BMI 28.31 18.59-46.72 5.42 27.82 20.61-43.58 5.00 0.41
Age 62 42-81 9.43 63 41-84 9.51 0.83
ASES-Pain 57.47 10-98 20.49 54.33 10-100 23.62 0.33
ASES-Function 74.81 34-100 17.37 73.59 28-100 19.88 0.35
ASES-Other symtoms 66.78 15-100 19.43 67.31 17-100 23.68 0.12
EQ5D-index 0.58 -0.022-0.79 0.25 0.56 -0.13-1.01 0.30 0.14
EQ5D-VAS 63.52 0-100 21.81 65.73 20-100 22.19 0.62
GAT total 22.87 12-79.39 10.09 24.67 14-47.81 7.83 0.45
GAT 1 7.89 1.81-39.59 5.52 7.91 3.62-18.01 3.29 0.47
GAT 2 4.28 2.00-14.02 2.48 5.12 2.03-16.19 2.68 0.18
GAT 3 10.49 5.38-28.82 3.72 11.90 5.41-28.79 4.58 0.19
SOLEO (sec) 33.55 0-60 22.02 35.71 0-60 23.00 0.60
SOLEC (sec) 6.18 0-30 6.31 6.82 0-30 7.09 0.58
One-legged jump (cm) 34.78 0-147 33.29 33.11 0-98 29.90 0.63
One-legged raising (as many times as possible) 9.00 0-31 8.89 12.03 0-48 12.73 0.83
Bipedal raising (as many times as possible) 15.00 3-50 12.10 13.10 0-30 8.40 0.61
OA location* (number) 3/21/21/16 2/18/16/17 0.71
Smokers (number) 5 9 0.36
BMI groups 20-25/25-30/>30 (number) 22/24/16 18/20/15 0.41
* hip/knee/hand/more than one location.
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Limitations of the study’s results
The information about height and weight was given by
the patients. Since weight is one of the factors that people
tend to underestimate, it is possible that this is the case
in our study too. However, still more than one third of
the patients were overweight and one third was obese.
GAT was designed for patients with rheumatoid
arthritis and is perhaps not sensitive enough to measure
differences in function among patients with osteoarthri-
tis, which might be considered in future studies. Also,
our patients come from a primary care setting, and even
if 60% of the patients had hand OA, their baseline
measure in GAT was better than in patients with rheu-
matoid arthritis, after one year of anti-TNF therapy [40].
It is possible that our patients reached the ceiling for
GAT already at baseline.
In EQ5D, changes from level 3 to level 2 give more
index weight than changes from level 2 to level 1. In
our study, the proportion of patients at level 3 in the 5
different dimensions at baseline was low. This may
explain the lack of statistically significant differences in
change in EQ5D index, even though more patients
improved from level 2 to level 1 in the intervention
group. Also, EQ5D has shown to be less sensitive to
change than other QOL measures [41] which also might
explain the lack of significant results in our study.
In the intervention, the first session of the PEPOA
contained a brainstorming about what the participants
found was hard to do in daily life. In the fourth session,
there was feedback on the brainstorming. The intention
was that these components in the PEPOA should affect
self-efficacy in a positive way, but no improvements in
self-efficacy were seen. Thus, brainstorming and feed-
back on brainstorming seems to be insufficient for
affecting self-efficacy and another approach than used in
our PEPOA is probably needed.
There were two options of one-leg rising, either from
48 cm or from 60 cm. There were 87 patients who man-
aged to rise from 48 cm, 47 in the intervention group
and 40 in the control group. Since the same height was
used for measures after 6 months as at baseline, we do
not think that this has influenced our results.
Patient education programmes have been shown to
improve self-efficacy and coping skills among patients
with low back pain [42], but not among patients with
arthritis in primary health care [43]. Our programme did
Figure 1 Flowchart of the study.
Table 3 Mean changes from baseline, mean difference, 95% CI of difference, p-value.
Intervention n = 61 Control n = 53
mean change mean change diff (CI) p
GAT total (points) -1.52 -1.69 0.17 (-2.56 to 2.91) 0.90
GAT 1 (points) -0.88 -0.06 0.82 (-2.43 to 0.79) 0.32
GAT 2 (points) -0.61 -1.24 0.63 (-0.21 to 1.46) 0.14
GAT 3 (points) 0.10 -0.53 0.63 (-0.69 to 2.07) 0.31
SOLEO (sec) -1.35 -3.94 2.59 (-3.29 to 8.47) 0.38
SOLEC (sec) 0.57 -1.13 1.17 (0.33 to 3.06) 0.02
One-legged jump (cm) -4.07 -7.55 3.48 (-7.08 to 14.04) 0.51
One-legged rising (times) 2.33 -1.08 3.41 (-2.07 to 8.89) 0.22
Bipedal rising (times) 1.30 -3.91 5.19 (-0.53 to 10.92) 0.10
ASES-Pain 4.94 4.08 0.86 (-6.72 to 8.44) 0.82
ASES-Function 3.89 -0.39 4.25 (-1.42 to 10.07) 0.14
ASES-Other symptoms 4.85 0.92 3.93 (-2.41 to 10.27) 0.23
EQ5D-index 0.07 0.00 0.07 (-0.02 to 10.17) 0.17
EQ5D-VAS 5.59 1.18 3.73 (-3.01 to 10.47) 0.02
In GAT, decrease means improvement, in all other tests, increase means improvement.
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not include exercises, but we still found significant differ-
ences in function and in self-perceived health, although
not in self-efficacy. Earlier reviews have led to contradic-
tory conclusions about the effect of patient education pro-
grammes for OA on function [9,14,15]. A patient
education programme for patients with knee pain has
been shown to reduce the number of consultations with
general practitioners [44], a variable that we have not con-
sidered in our study. It seems that our programme
succeeded in improving self-perceived health but not self-
efficacy, and it had only minor influence on function.
Nevertheless, it seems feasible in primary health care.
Dropouts
There were a total of 14 dropouts in the study. Data
were analysed on an intention-to-treat basis, with the
dropouts included and the last observation carried for-
ward [45]. There were more dropouts in the interven-
tion group than in the control group, 10 in the
intervention group and 4 in the control group. In the
intervention group, 6 patients dropped out before
receiving intervention and 4 after receiving intervention.
Reasons for dropping out were similar in the interven-
tion group and in the control group. Therefore we do
not think that the intervention itself affected whether
the patient dropped out or not.
Conclusion
This randomized controlled trial has shown that patient
education for patients with osteoarthritis is feasible in a
primary health care setting and can improve self-
perceived health as well as function in some degree, but not
self-efficacy. The current programme included education
rather than instruction in exercise, and further research to
investigate the effect of exercise performance on function,
as well as self-efficacy is warranted.
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